/PRNewswire/ The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By.
Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat.
U.S. futures for the S&P 500 were down 0.3% and futures for the Dow Jones Industrial Average decreased 0.3%. Changes in futures do not necessarily predict.